APR 14, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Bosentan (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval for bosentan labeling update; regulatory action does not report clinical trial outcomes or comparative efficacy data.
Reported
Approval date2026-04-14
Product strengths approved62.5 mg, 125 mg